270 related articles for article (PubMed ID: 11751387)
1. Normalization of elevated hepatic 8-hydroxy-2'-deoxyguanosine levels in chronic hepatitis C patients by phlebotomy and low iron diet.
Kato J; Kobune M; Nakamura T; Kuroiwa G; Takada K; Takimoto R; Sato Y; Fujikawa K; Takahashi M; Takayama T; Ikeda T; Niitsu Y
Cancer Res; 2001 Dec; 61(24):8697-702. PubMed ID: 11751387
[TBL] [Abstract][Full Text] [Related]
2. Hepatic oxidative DNA damage correlates with iron overload in chronic hepatitis C patients.
Fujita N; Horiike S; Sugimoto R; Tanaka H; Iwasa M; Kobayashi Y; Hasegawa K; Ma N; Kawanishi S; Adachi Y; Kaito M
Free Radic Biol Med; 2007 Feb; 42(3):353-62. PubMed ID: 17210448
[TBL] [Abstract][Full Text] [Related]
3. 8-Hydroxy-2'-deoxy-guanosine is a risk factor for development of hepatocellular carcinoma in patients with chronic hepatitis C virus infection.
Chuma M; Hige S; Nakanishi M; Ogawa K; Natsuizaka M; Yamamoto Y; Asaka M
J Gastroenterol Hepatol; 2008 Sep; 23(9):1431-6. PubMed ID: 18854000
[TBL] [Abstract][Full Text] [Related]
4. Comparison of hepatic oxidative DNA damage in patients with chronic hepatitis B and C.
Fujita N; Sugimoto R; Ma N; Tanaka H; Iwasa M; Kobayashi Y; Kawanishi S; Watanabe S; Kaito M; Takei Y
J Viral Hepat; 2008 Jul; 15(7):498-507. PubMed ID: 18331251
[TBL] [Abstract][Full Text] [Related]
5. Additional effect of low iron diet on iron reduction therapy by phlebotomy for chronic hepatitis C.
Kimura F; Hayashi H; Yano M; Yoshioka K; Matsumura T; Fukuda T; Shigeto N; Yamahara S; Koushi F; Mishima Y; Yoshino T; Tanimoto M; Kimura I
Hepatogastroenterology; 2005; 52(62):563-6. PubMed ID: 15816478
[TBL] [Abstract][Full Text] [Related]
6. Iron reduction before and during interferon therapy of chronic hepatitis C: results of a multicenter, randomized, controlled trial.
Fontana RJ; Israel J; LeClair P; Banner BF; Tortorelli K; Grace N; Levine RA; Fiarman G; Thiim M; Tavill AS; Bonkovsky HL
Hepatology; 2000 Mar; 31(3):730-6. PubMed ID: 10706565
[TBL] [Abstract][Full Text] [Related]
7. Iron reduction and sustained response to interferon-alpha therapy in patients with chronic hepatitis C: results of an Italian multicenter randomized study.
Fargion S; Fracanzani AL; Rossini A; Borzio M; Riggio O; Belloni G; Bissoli F; Ceriani R; Ballarè M; Massari M; Trischitta C; Fiore P; Orlandi A; Morini L; Mattioli M; Oldani S; Cesana B; Fiorelli G
Am J Gastroenterol; 2002 May; 97(5):1204-10. PubMed ID: 12014729
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of 8-nitroguanine in the liver of patients with chronic hepatitis C.
Horiike S; Kawanishi S; Kaito M; Ma N; Tanaka H; Fujita N; Iwasa M; Kobayashi Y; Hiraku Y; Oikawa S; Murata M; Wang J; Semba R; Watanabe S; Adachi Y
J Hepatol; 2005 Sep; 43(3):403-10. PubMed ID: 16023246
[TBL] [Abstract][Full Text] [Related]
9. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: a multicenter, prospective, randomized, controlled trial.
Di Bisceglie AM; Bonkovsky HL; Chopra S; Flamm S; Reddy RK; Grace N; Killenberg P; Hunt C; Tamburro C; Tavill AS; Ferguson R; Krawitt E; Banner B; Bacon BR
Hepatology; 2000 Jul; 32(1):135-8. PubMed ID: 10869301
[TBL] [Abstract][Full Text] [Related]
10. Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C.
Yano M; Hayashi H; Wakusawa S; Sanae F; Takikawa T; Shiono Y; Arao M; Ukai K; Ito H; Watanabe K; Yoshioka K
Am J Gastroenterol; 2002 Jan; 97(1):133-7. PubMed ID: 11808937
[TBL] [Abstract][Full Text] [Related]
11. Iron depletion and response to interferon in chronic hepatitis C.
Carlo C; Daniela P; Giancarlo C
Hepatogastroenterology; 2003; 50(53):1467-71. PubMed ID: 14571765
[TBL] [Abstract][Full Text] [Related]
12. Effect of iron depletion on serum markers of fibrogenesis, oxidative stress and serum liver enzymes in chronic hepatitis C: results of a pilot study.
Alexander J; Tung BY; Croghan A; Kowdley KV
Liver Int; 2007 Mar; 27(2):268-73. PubMed ID: 17311623
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of iron status in patients with chronic hepatitis C.
Sartori M; Andorno S; La Terra G; Boldorini R; Leone F; Pittau S; Zecchina G; Aglietta M; Saglio G
Ital J Gastroenterol Hepatol; 1998 Aug; 30(4):396-401. PubMed ID: 9789136
[TBL] [Abstract][Full Text] [Related]
14. Effect of blood letting on serum aminotransferase levels of patients with chronic hepatitis C and iron overload.
Girelli CM; Mirata C; Casiraghi A
Recenti Prog Med; 1998 May; 89(5):241-4. PubMed ID: 9676130
[TBL] [Abstract][Full Text] [Related]
15. Glucose abnormalities in non-alcoholic fatty liver disease and chronic hepatitis C virus infection: the role of iron overload.
Lecube A; Hernández C; Simó R
Diabetes Metab Res Rev; 2009 Jul; 25(5):403-10. PubMed ID: 19444865
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of long-term dietary restriction of total calories, fat, iron, and protein in patients with chronic hepatitis C virus.
Iwasa M; Iwata K; Kaito M; Ikoma J; Yamamoto M; Takeo M; Kuroda M; Fujita N; Kobayashi Y; Adachi Y
Nutrition; 2004 Apr; 20(4):368-71. PubMed ID: 15043853
[TBL] [Abstract][Full Text] [Related]
17. Iron overload in patients with chronic hepatitis C virus infection: clinical and histological study.
Silva IS; Perez RM; Oliveira PV; Cantagalo MI; Dantas E; Sisti C; Figueiredo-Mendes C; Lanzoni VP; Silva A; Ferraz ML
J Gastroenterol Hepatol; 2005 Feb; 20(2):243-8. PubMed ID: 15683427
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum ferritin, hepatic iron staining, diabetes mellitus and fibrosis progression in patients with chronic hepatitis C.
D'Souza RF; Feakins R; Mears L; Sabin CA; Foster GR
Aliment Pharmacol Ther; 2005 Mar; 21(5):519-24. PubMed ID: 15740534
[TBL] [Abstract][Full Text] [Related]
19. [Effect of iron depletion on long-term response to interferon in patients with chronic hepatitis C with increased plasma iron without accumulation of liver iron].
Cagnoni C; Corsini F; Pancotti D; Carrara G
Ann Ital Med Int; 2000; 15(2):132-8. PubMed ID: 10920503
[TBL] [Abstract][Full Text] [Related]
20. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron.
Hayashi H; Takikawa T; Nishimura N; Yano M; Isomura T; Sakamoto N
Am J Gastroenterol; 1994 Jul; 89(7):986-8. PubMed ID: 8017395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
